Irhythm Technologies Inc (NASDAQ:IRTC) CFO Matthew C. Garrett sold 1,193 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $55.00, for a total value of $65,615.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Irhythm Technologies Inc (NASDAQ IRTC) traded up $0.02 during trading on Tuesday, reaching $52.31. The company’s stock had a trading volume of 225,540 shares, compared to its average volume of 263,548. Irhythm Technologies Inc has a 12-month low of $24.25 and a 12-month high of $57.90. The company has a debt-to-equity ratio of 0.38, a quick ratio of 7.57 and a current ratio of 7.65.

Irhythm Technologies (NASDAQ:IRTC) last issued its earnings results on Wednesday, November 1st. The company reported ($0.29) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.34) by $0.05. The firm had revenue of $25.04 million for the quarter, compared to the consensus estimate of $24.30 million. Irhythm Technologies had a negative return on equity of 27.67% and a negative net margin of 27.56%. The company’s revenue was up 49.2% compared to the same quarter last year. During the same quarter last year, the business posted ($2.80) EPS. equities research analysts expect that Irhythm Technologies Inc will post -1.17 earnings per share for the current fiscal year.

A number of equities analysts have commented on the company. Zacks Investment Research lowered Irhythm Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Royal Bank Of Canada assumed coverage on Irhythm Technologies in a research note on Monday. They set an “outperform” rating and a $79.00 price objective on the stock. Canaccord Genuity raised their price objective on Irhythm Technologies from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. ValuEngine upgraded Irhythm Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, October 21st. Finally, Dougherty & Co assumed coverage on Irhythm Technologies in a research note on Friday. They set a “neutral” rating on the stock. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $65.25.

Several hedge funds have recently modified their holdings of the business. Capital Research Global Investors boosted its holdings in shares of Irhythm Technologies by 103.2% in the 2nd quarter. Capital Research Global Investors now owns 2,399,180 shares of the company’s stock valued at $101,941,000 after purchasing an additional 1,218,580 shares in the last quarter. FMR LLC boosted its holdings in shares of Irhythm Technologies by 382.2% in the 2nd quarter. FMR LLC now owns 1,542,886 shares of the company’s stock valued at $65,557,000 after purchasing an additional 1,222,886 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Irhythm Technologies by 5.0% in the 2nd quarter. Franklin Resources Inc. now owns 1,109,613 shares of the company’s stock valued at $47,147,000 after purchasing an additional 53,260 shares in the last quarter. TimesSquare Capital Management LLC boosted its holdings in shares of Irhythm Technologies by 43.7% in the 2nd quarter. TimesSquare Capital Management LLC now owns 1,060,230 shares of the company’s stock valued at $45,049,000 after purchasing an additional 322,300 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in shares of Irhythm Technologies by 644.3% in the 2nd quarter. Alliancebernstein L.P. now owns 883,986 shares of the company’s stock valued at $37,561,000 after purchasing an additional 765,218 shares in the last quarter. 97.80% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Insider Selling: Irhythm Technologies Inc (IRTC) CFO Sells 1,193 Shares of Stock” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/05/insider-selling-irhythm-technologies-inc-irtc-cfo-sells-1193-shares-of-stock.html.

Irhythm Technologies Company Profile

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Insider Buying and Selling by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for Irhythm Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.